4d Molecular Therapeutics, Inc. · NASDAQ:FDMT

Kirn David sold 58,333 4d Molecular Therapeutics, Inc. shares (Form 4)

Traded Oct 5, 2026 · Filed Oct 7, 2026

On Oct 5, 2026, Kirn David (Director, See Remarks) sold 58,333 4d Molecular Therapeutics, Inc. shares at an average US$12.92 for US$754K under a trading plan, leaving 709,153 shares. Filed Oct 7, 2026 (Form 4).

Sold
58,333 shares
Price
US$12.92 average (US$12.92 to US$13.61)
Value
US$754K
Holding after
709,153 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, See Remarks

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Oct 5, 2026Common StockSale58,061US$12.92709,425Direct
Oct 5, 2026Common StockSale272US$13.61709,153Direct

Source

View original at SEC

Related